Press release: Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. Commentaries: Johnson & Johnson says additional dose boosts Covid vaccine efficacy – STAT J&J booster 94% effective against severe COVID, company says – CIDRAP Two dose version of Johnson & Johnson […]

The post [Press release – not published yet] J&J says booster shot at two months provided 75% protection against moderate to severe COVID-19 globally and 94% of such cases in the U.S. appeared first on Links Medicus.